[1]
|
Albini, A. and Sporn, M. (2007) The Tumour Microenvironment as a Target for Chemoprevention. Nature Reviews Cancer, 7, 139-147. http://dx.doi.org/10.1038/nrc2067
|
[2]
|
Abate, S. and Shen, M. (2000) Molecular Genetics of Prostate Cancer. Genes Development, 14, 2410-2434.
http://dx.doi.org/10.1101/gad.819500
|
[3]
|
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M. and Boyle, P. (2007) Estimates of the Cancer Incidence and Mortality in Europe. Annals of Oncology, 18, 581-592. http://dx.doi.org/10.1093/annonc/mdl498
|
[4]
|
Pisani, P., Parkin, M., Munoz, N. and Ferlay, J. (1997) Cancer and Infection: Estimates of the Attributable Fraction in 1990. Cancer Epidemiology, Biomarkers Prevention, 6, 387-400.
|
[5]
|
Klein, E. and Silverman, R. (2008) Inflammation, Infection, and Prostate Cancer. Current Opinion in Urology, 18, 315-319. http://dx.doi.org/10.1097/MOU.0b013e3282f9b3b7
|
[6]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? Lancet, 357, 539-545.
http://dx.doi.org/10.1016/S0140-6736(00)04046-0
|
[7]
|
Nelson, W, Sfanos, K., DeMarzo, A. and Yegnasubramanian, S. (2013) Prostate Inflammation and Prostate Cancer. Management of Prostate Cancer, 4, 103-115.
|
[8]
|
Lee, J., Demissie, K., Lu, S. and Rhoads, G. (2007) Cancer Incidence among Korean-American Immigrants in the United States and Native Koreans in South Korea. Cancer Control, 14, 78-85.
|
[9]
|
Sfanos, K. and Marzo, M. (2012) Prostate Cancer and Inflammation: The Evidence. Histopathology, 60, 199-215.
http://dx.doi.org/10.1111/j.1365-2559.2011.04033.x
|
[10]
|
Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
http://dx.doi.org/10.1038/nature07205
|
[11]
|
Chughtai, B., Lee, R., Te, A. and Kaplan, S. (2011) Role of Inflammation in Benign Prostatic Hyperplasia. Reviews in Urology, 13, 147-150.
|
[12]
|
Fibbi, B., Penna, G., Morelli, A., Adorini, L. and Maggi, M. (2010) Chronic Inflammation in the Pathogenesis of Benign Prostatic Hyperplasia. International Journal of Andrology, 33, 475-488.
http://dx.doi.org/10.1111/j.1365-2605.2009.00972.x
|
[13]
|
Koopmann, W. and Krangel, M. (1997) Identification of a Glycosaminoglycan-Binding Site in Chemokine Macrophage Inflammatory Protein-1α. The Journal of Biological Chemistry, 272, 10103-10109.
http://dx.doi.org/10.1074/jbc.272.15.10103
|
[14]
|
Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867.
http://dx.doi.org/10.1038/nature01322
|
[15]
|
Shacter, E. and Weitzman, S. (2002) Chronic Inflammation and Cancer. Oncology, 16, 217-226.
|
[16]
|
Jackson, R., Seed, M., Kircher, C., Willoughby, D. and Winkler, J. (1997) The Codependence of Angiogenesis and Chronic Inflammation. FASEB Journal, 11, 457-465.
|
[17]
|
Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. and Loguercio, C. (2007) Chronic Inflammation and Oxidative Stress in Human Carcinogenesis. International Journal of Cancer, 121, 2381-2386. http://dx.doi.org/10.1002/ijc.23192
|
[18]
|
Sies, H. (1997) Oxidative Stress: Oxidants and Antioxidants. Experimental Physiology, 82, 291-295.
|
[19]
|
Finkel, T. and Holbrook, N. (2000) Oxidants, Oxidative Stress and the Biology of Ageing. Nature, 408, 239-247.
http://dx.doi.org/10.1038/35041687
|
[20]
|
Naber, K. and Weidner, W. (2000) Chronic Prostatitis—An Infectious Disease? Journal of Antimicrobial Chemotherapy, 46, 157-161. http://dx.doi.org/10.1093/jac/46.2.157
|
[21]
|
Sugar, L. (2006) Inflammation and Prostate Cancer. Canadian Journal of Urology, 13, 46-47.
|
[22]
|
Josson, S., Matsuoka, Y., Chung, L., Zhau, H. and Wang, R. (2010) Tumor-Stroma Co-Evolution in Prostate Cancer Progression and Metastasis. Seminars in Cell & Developmental Biology, 21, 26-32.
http://dx.doi.org/10.1016/j.semcdb.2009.11.016
|
[23]
|
Sun, S., Sprenger, C., Vessella, R., Haugk, K., Soriano, K., Mostaghel, E., Page, S., Coleman, I., Nguyen, H., Sun, H., Nelson, P. and Plymate, S. (2010) Castration Resistance in Human Prostate Cancer Is Conferred by a Frequently Occurring Androgen Receptor Splice Variant. Journal of Clinical Investigation, 120, 2715-2730.
http://dx.doi.org/10.1172/JCI41824
|
[24]
|
Nguyen, D., Li, J., Yadav, S. and Tewari, A. (2013) Recent Insights into NF-κB Signalling Pathways and the Link between Inflammation and Prostate Cancer. BJU International, 4, 23-28.
|
[25]
|
Karin, M. and Lin, A. (2009) NF-κB at the Crossroads of Life and Death. Nature Immunology, 3, 221-227.
http://dx.doi.org/10.1038/ni0302-221
|
[26]
|
Stock, D., Groome, A. and Siemens, R. (2008) Inflammation and Prostate Cancer. A Future Target for Prevention and therapy? Urologic Clinics of North America, 35, 117-130. http://dx.doi.org/10.1016/j.ucl.2007.09.006
|
[27]
|
Shukla, S., MacLennan, G., Marengo, R., Resnick, M. and Gupta, S. (2004) Nuclear Factor κB/p65 (Rel A) Is Constitutively Activated in Human Prostate Adenocarcinoma and Correlates with Disease Progression. Neoplasia, 6, 390-400.
http://dx.doi.org/10.1593/neo.04112
|
[28]
|
Suh, J., Payvandi, F., Edelstein, L., Amenta, P., Zong, W., Gélinas, C. and Rabson, A. (2002) Mechanisms of Constitutive NF-κB Activation in Human Prostate Cancer Cells. The Prostate, 52, 183-200.
http://dx.doi.org/10.1002/pros.10082
|
[29]
|
Pahl, H. (1999) Activators and Target Genes of Rel/NF-κB Transcription Factors. Oncogene, 18, 6853-6866.
http://dx.doi.org/10.1038/sj.onc.1203239
|
[30]
|
Mantovani, A. (2009) Cancer: Inflaming Metastasis. Nature, 457, 36-37. http://dx.doi.org/10.1038/457036b
|
[31]
|
Pollard, J. (2004) Tumour-Educated Macrophages Promote Tumour Progression and Metastasis. Nature Reviews Cancer, 4, 71-78. http://dx.doi.org/10.1038/nrc1256
|
[32]
|
Locksley, R., Killeen, N. and Lenardo, M. (2001) The TNF and TNF Receptor Superfamilies: Integrating Mammalian Biology. Cell, 104, 487-501. http://dx.doi.org/10.1016/S0092-8674(01)00237-9
|
[33]
|
Nakashima, J., Tachibana, M., Ueno, M., Miyajima, A., Baba, S. and Murai, M. (1998) Association between Tumor Necrosis Factor in Serum and Cachexia in Patients with Prostate Cancer. Clinical Cancer Research, 4, 1743-1748.
|
[34]
|
Irie, A., Lee, K., Kadowaki, K., Toda, K. and Yamada, Y. (1999) Elevation of Serum and Urine Tumor Necrosis Factor Levels after Transurethral Resection of the Prostate. Nippon Hinyokika Gakkai Zasshi, 90, 502-508.
|
[35]
|
Nakajima, Y., Dellipizzi, A., Mallouh, C. and Ferreri, N. (1996) TNF-Mediated Cytotoxicity and Resistance in Human Prostate Cancer Cell Lines. The Prostate, 6, 296-302.
|
[36]
|
Davis, J., Nastiuk, K. and Krolewski, J. (2012) TNF Is Necessary for Castration-Induced Prostate Regression, Whereas TRAIL and FasL Are Dispensable. The Journal of Clinical Endocrinology and Metabolism, 96, 873.
http://dx.doi.org/10.1210/jcem.96.3.zeg873a.
|
[37]
|
Alcover, J., Filella, X., Luque, P., Molina, R., Izquierdo, L., Maria, J. and Alcaraz, A. (2010) Prognostic Value of IL-6 in Localized Prostatic Cancer. Anticancer Research, 30, 4369-4372.
|
[38]
|
Nguyen, D., Li, J. and Tewari, A. (2013) Inflammation and Prostate Cancer: The Role of Interleukin-6. BJU International, Published Online.
|
[39]
|
Chung, Y. and Chang, Y. (2003) Serum Interleukin-6 Levels Reflect the Disease Status of Colorectal Cancer. Journal of Surgical Oncology, 83, 222-226. http://dx.doi.org/10.1002/jso.10269
|
[40]
|
Shariat, S., Chromecki, T., Hoefer, J., Barbieri, C., Scherr, D., Karakiewicz, P., Roehrborn, C., Montorsi, F., Culig, Z. and Cavarretta, T. (2011) Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner. The Journal of Urology, 186, 2107-2114.
http://dx.doi.org/10.1016/j.juro.2011.06.048
|
[41]
|
Deeble, P., Murphy, D., Parsons, S. and Cox, M. (2001) Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells. Molecular and Cellular Biology, 21, 8471-8482.
http://dx.doi.org/10.1128/MCB.21.24.8471-8482.2001
|
[42]
|
Joseph, L., Jian, Z., Jill, A. and Evan, T. (2011) The PCa Tumor Microenvironment. Cancer Microenviron- ment, 4, 283-297. http://dx.doi.org/10.1007/s12307-011-0073-8
|
[43]
|
Blaszczyk, N., Masri, B., Mawji, N., Ueda, T., McAlinden, G., Duncan, C., Bruchovsky, N., Schweikert, H., Schnabel, D., Jones, E. and Sadar, M. (2004) Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells. Clinical Cancer Research, 10, 1860-1869.
http://dx.doi.org/10.1158/1078-0432.CCR-0974-3
|
[44]
|
Kosaka, T., Miyata, A., Ihara, H., Hara, S., Sugimoto, T., Takeda, O., Takahashi, E. and Tanabe, T. (1994) Characterization of the Human Gene (PTGS2) Encoding Prostaglandin-Endoperoxide Synthase 2. European Journal of Biochemistry, 221, 889-897. http://dx.doi.org/10.1111/j.1432-1033.1994.tb18804.x
|
[45]
|
Van der Giet, M., Tolle, M. and Kleuser, B. (2008) Relevance and Potential of Sphingosine-1-Phosphate in Vascular Inflammatory Disease. Biological Chemistry, 389, 1381-1390. http://dx.doi.org/10.1515/BC.2008.165?
|
[46]
|
McCarty, M. (2004) Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy. Integrative & Complementary Medicine, 3, 349-380.
http://dx.doi.org/10.1177/1534735404270757
|
[47]
|
Mahmud, S., Franco, E. and Aprikian, A. (2004) Prostate Cancer and Use of Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis. British Journal of Cancer, 90, 93-99. http://dx.doi.org/10.1038/sj.bjc.6601416
|
[48]
|
Inoue, K., Slaton, J., Eve, B., Kim, S., Perrotte, P., Balbay, M., Yano, S., Bar-Eli, M., Radinsky, R., Pettaway, C. and Dinney, C. (2000) Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-Independent Prostate Cancer. Clinical Cancer Research, 6, 2104-2119
|
[49]
|
Uehara, H., Troncoso, P., Johnston, D., Bucana, C., Dinney, C., Dong, Z., Fidler, I. and Pettaway, C. (2005) Expression of Interleukin-8 Gene in Radical Prostatectomy Specimens Is Associated with Advanced Pathologic Stage. The Prostate, 64, 40-49. http://dx.doi.org/10.1002/pros.20223
|
[50]
|
Steiner, G., Newman, M., Paikl, D., Stix, U., Memaran-Dagda, N., Lee, C. and Marberger, M. (2003) Expression and Function of Pro-Inflammatory Interleukin IL-17 and IL-17 Receptor in Normal, Benign Hyperplastic, and Malignant Prostate. The Prostate, 56, 171-182. http://dx.doi.org/10.1002/pros.10238
|